Human ceIII ine derived from uterine cervix cancer. Adenocarcinoma . 5aid producing CEA, CA125 , TPA.

Human ceIII ine derived from uterine cervix
cancer. Adenocarcinoma . 5aid producing
CEA, CA125 , TPA. Struktur
CAS-Nr.
Englisch Name:
Human ceIII ine derived from uterine cervix cancer. Adenocarcinoma . 5aid producing CEA, CA125 , TPA.
Synonyma:
TCO-2;Human ceIII ine derived from uterine cervix cancer. Adenocarcinoma . 5aid producing CEA, CA125 , TPA.
CBNumber:
CB221460681
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

Human ceIII ine derived from uterine cervix cancer. Adenocarcinoma . 5aid producing CEA, CA125 , TPA. Eigenschaften

Sicherheit

Human ceIII ine derived from uterine cervix cancer. Adenocarcinoma . 5aid producing CEA, CA125 , TPA. Chemische Eigenschaften,Einsatz,Produktion Methoden

Human ceIII ine derived from uterine cervix cancer. Adenocarcinoma . 5aid producing CEA, CA125 , TPA. Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Human ceIII ine derived from uterine cervix cancer. Adenocarcinoma . 5aid producing CEA, CA125 , TPA. Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Guangdong Fanpu Biotechnology Co., Ltd. 19513720913
2708713838@qq.com China 4720 58

  • Human ceIII ine derived from uterine cervix cancer. Adenocarcinoma . 5aid producing CEA, CA125 , TPA.
  • TCO-2
Copyright 2019 © ChemicalBook. All rights reserved